Preventing tumour recurrence | Fonds Anticancer (FR)
Preventing tumour recurrence icon

Preventing tumour recurrence

For cancer survivors, the fight isn’t always over. Many are concerned about the possibility of recurrence, and living with uncertainty is never easy. Discovering an intervention that can prevent cancer recurrence has the potential to significantly enhance quality of life.

Preventing tumour recurrence

Fighting the main threat: metastasis

Evidence is occasionally discovered supporting various, often simple interventions that improve existing treatment protocols. These additional therapies prevent tumour recurrence and contribute significantly to better outcomes. With 90% of deaths resulting from tumour recurrence and metastasis, primary tumours are not the main threat. While the mechanism of action of several interventions are not yet fully understood, research indicates that their influence on dormant cancer cells and the body’s own cancer-fighting mechanisms are at the core of their potential.

90%
of deaths
due to tumour recurrence

Our trials in this focus area

Trial phase: 
3
Cancer types: 
  • Melanoma
Status: 
Recruiting
Trial phase: 
3
Cancer types: 
  • Digestive cancer
Status: 
Recruiting
Trial phase: 
3
Cancer types: 
  • Breast cancer
Status: 
Completed

Notre focus actuel

  • Drug repurposing

    [en anglais] Drug repurposing, also known as drug repositioning, is a drug development strategy predicated on the reuse...
  • Les cancers moins courants et rares

    [en anglais] We don’t just focus on the ‘big four’ of cancer – prostate, colon, breast and lung. We also investigate...
  • Thérapies combinées

    [en anglais] It is important to investigate the impacts of drugs beyond what they can achieve alone. Using them in...
  • Prévenir la récidive des tumeurs

    [en anglais] For cancer survivors, the fight isn’t always over. Many are concerned about the possibility of recurrence...

Demandez un financement